Cubist Pharmaceuticals Acquires Adynxx for Undisclosed Sum
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5f623379-f5df-4cc7-a84e-5c45a9175d46&Preview=1 -
Date
2/25/2013 -
Company Name
Adynxx -
Mailing Address
731 Market St. San Francisco, CA 94103 -
Company Description
The company is dedicated to developing the next breakthrough therapeutic treatments for chronic pain. -
Website
http://www.adynxx.com -
Transaction Type
M&A -
Transaction Amount
Undisclosed -
Transaction Round
-
Proceeds Purposes
-
M&A Terms
Financial terms of the transaction were not disclosed by the parties.
